Latest Australian Market News

Future Generation Australia (ASX: FGX) reported a robust 20.1% total shareholder return for the year to June 2026 alongside an increased fully franked interim dividend of 3.8 cents per share, maintaining its commitment to steady income and social impact.

CDC’s independent valuation jumped 23.6% to a mid-point of A$18.5 billion, propelled by contracted capacity exceeding 1GW and a major pipeline expansion to 3.9GW. Infratil’s nearly 50% stake now values at over A$9.2 billion.

Global X Management (AUS) Limited is trimming the management fee for its Australia 300 ETF (ASX: A300) by 25%, effective 1 July 2026, reflecting a subtle but meaningful cost saving for investors.

Enlitic has landed its inaugural Australian Ensight subscription contract with Lumus Imaging, marking a strategic entry into the local SaaS market and expanding its footprint in diagnostic imaging workflows.

Biome Australia has posted a 30% increase in FY26 sales revenue to $23.9 million, driven by strong domestic demand and strategic moves into onshore manufacturing and international markets.

ARN Media is selling its Hong Kong out-of-home advertising business, Cody HK, to DFI Retail Group for HK$30.2 million, marking a strategic exit from non-core assets to sharpen focus on Australian operations.

4DMedical has cleared a major regulatory hurdle with the Therapeutic Goods Administration approving its CT:VQ™ lung imaging software, paving the way for commercial use across Australia and strengthening its global footprint.

Vinyl Group has completed its acquisition of Time Out Australia, securing exclusive rights to the brand and expanding its media reach across digital and events platforms.

EROAD Limited reported stable FY26 revenue of NZD 195 million amid a $134.7 million North American impairment, unveiling a strategic reset centred on ANZ growth and its expanding electronic Road User Charges platform.

Acrow Limited (ASX:ACF) is set to expand its Industrial Access and Construction Services footprint with a $54.5 million acquisition of Ausgroup and Preston SuperDeck, funded by a fully underwritten $70 million equity raise and a $10 million share purchase plan. The company also upgraded its FY27 revenue and EBITDA guidance by 21% and 15% respectively.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.

Transurban has finished a major NSW motorway upgrade that promises faster commutes and better airport access, while agreeing to sell its remaining share in a Montreal toll road for CAD 280 million.